1. Insogna KL. Primary Hyperparathyroidism. N Engl J Med. 2018; 379:1050–1059.
Article
2. Marcocci C, Cetani F. Clinical practice. Primary hyperparathyroidism. N Engl J Med. 2011; 365:2389–2397.
3. Cogan MG, Covey CM, Arieff AI, Wisniewski A, Clark OH, Lazarowitz V, et al. Central nervous system manifestations of hyperparathyroidism. Am J Med. 1978; 65:963–970.
Article
4. Turken SA, Cafferty M, Silverberg SJ, De La Cruz L, Cimino C, Lange DJ, et al. Neuromuscular involvement in mild, asymptomatic primary hyperparathyroidism. Am J Med. 1989; 87:553–557.
Article
5. Logullo F, Babbini MT, Di Bella P, Provinciali L. Reversible combined cognitive impairment and severe polyneuropathy resulting from primary hyperparathyroidism. Ital J Neurol Sci. 1998; 19:86–89.
Article
6. Gentric A, Jezequel J, Pennec YL. Severe neuropathy related to primary hyperparathyroidism cured by parathyroidectomy. J Am Geriatr Soc. 1993; 41:759.
Article
7. Delbridge LW, Marshman D, Reeve TS, Crummer P, Posen S. Neuromuscular symptoms in elderly patients with hyperparathyroidism: improvement with parathyroid surgery. Med J Aust. 1988; 149:74–76.
Article
8. Diniz ET, Bandeira F, Lins OG, Cavalcanti ÉN, de Arruda TM, Januário AM, et al. Primary hyperparathyroidism is associated with subclinical peripheral neural alterations. Endocr Pract. 2013; 19:219–225.
Article
9. Schlaepfer WW, Bunge RP. Effects of calcium ion concentration on the degeneration of amputated axons in tissue culture. J Cell Biol. 1973; 59(2 Pt 1):456–470.
Article